References
- Abraha, I., Rimland, J. M., Trotta, F. M., Dell’Aquila, G., Cruz-Jentoft, A., Petrovic, M., … Cherubini, A. (2017). Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open, 7(3), e012759. doi:https://doi.org/10.1136/bmjopen-2016-012759.
- Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140. doi:https://doi.org/10.1097/XEB.0000000000000055
- Banerjee, S. (2009). The use of antipsychotic medication for people with dementia: Time for action. London: Department of Health.
- Birkenhäger-Gillesse, E., Kollen, B., Achterberg, W., Boersma, F., Jongman, L., & Zuidema, S. (2018). Effects of psychosocial interventions for behavioral and psychological symptoms in dementia on the prescription of psychotropic drugs: A systematic review and meta-analyses. Journal of the American Medical Directors Association, 19(3), 276.e1–e9. doi:https://doi.org/10.1016/j.jamda.2017.12.100
- Caspar, S., Davis, E. D., Douziech, A., & Scott, D. R. (2018). Nonpharmacological management of behavioral and psychological symptoms of dementia: What works, in what circumstances, and why? Innovation in Aging, 2(1), igy001. doi:https://doi.org/10.1093/geroni/igy001
- Critical Appraisal Skills Programme. (2019). CASP systematic review checklist. https://casp-uk.net/wp-content/uploads/2018/01/CASP-Qualitative-Checklist-2018.pdf.
- Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I. M., van Driel, M. L., & Christiaens, T. (2013). Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database of Systematic Reviews, 3, CD007726. doi:https://doi.org/10.1002/14651858.CD007726.pub2
- Department of Health. (2019). Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia (NCEC National Clinical Guideline No. 21). Department of Health: Dublin. https://www.gov.ie/en/collection/ac0046-appropriate-prescribing-of-psychotropic-medication-for-non-cognitive/
- Donoghue, C. (2010). Nursing home staff turnover and retention: An analysis of national level data. Journal of Applied Gerontology, 29(1), 89–106. doi:https://doi.org/10.1177/0733464809334899
- Dudas, R., Malouf, R., McCleery, J., & Dening, T. (2018). Antidepressants for treating depression in dementia. Cochrane Database of Systematic Reviews, 8(8), CD003944. doi:https://doi.org/10.1002/14651858.CD003944.pub2
- Dupuis, S. L., Wiersma, E., & Loiselle, L. (2012). Pathologizing behavior: Meanings of behaviors in dementia care. Journal of Aging Studies, 26(2), 162–173. doi:https://doi.org/10.1016/j.jaging.2011.12.001
- Dyer, S. M., Harrison, S. L., Laver, K., Whitehead, C., & Crotty, M. (2018). An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. International Psychogeriatrics, 30(3), 295–309. doi:https://doi.org/10.1017/S1041610217002344
- Erens, B., Dickson, K., Lafortune, L., Kavanagh, J., Thomas, J., & Mays, N. (2012). Non-drug treatments for symptoms in dementia: An overview of systematic reviews of non-pharmacological interventions in the management of neuropsychiatric symptoms and challenging behaviours in patients with dementia. Technical Report. London, Policy Research Unit in Policy Innovation Research (PIRU). doi:https://doi.org/10.17037/PUBS.02478760
- Fiest, K. M., Jetté, N., Roberts, J. I., Maxwell, C. J., Smith, E. E., Black, S. E., … Hogan, D. B. (2016). The prevalence and incidence of dementia: A systematic review and meta-analysis. Canadian Journal of Neurological Sciences, 43(S1), S3–S50. doi:https://doi.org/10.1017/cjn.2016.18
- Groot Kormelinck, C. M., Janus, S. I. M., Smalbrugge, M., Gerritsen, D. L., & Zuidema, S. U. (2020). Systematic review on barriers and facilitators of complex interventions for residents with dementia in long-term care. International Psychogeriatrics, 1–17. doi:https://doi.org/10.1017/S1041610220000034
- Harrison, S. L., Cations, M., Jessop, T., Hilmer, S. N., Sawan, M., & Brodaty, H. (2019). Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia. Drugs & Aging, 36(2), 125–136. doi:https://doi.org/10.1007/s40266-018-0623-6
- Hoyle, D. J., Bindoff, I. K., Clinnick, L. M., Peterson, G. M., & Westbury, J. L. (2018). Clinical and economic outcomes of interventions to reduce antipsychotic and benzodiazepine use within nursing homes: A systematic review. Drugs & Aging, 35(2), 123–134. doi:https://doi.org/10.1007/s40266-018-0518-6
- Jalbert, J. J., Eaton, C. B., Miller, S. C., & Lapane, K. L. (2010). Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. Journal of the American Medical Directors Association, 11(2), 120–127. doi:https://doi.org/10.1016/j.jamda.2009.10.001
- Janus, S. I. M., van Manen, J. G., IJzerman, M. J., & Zuidema, S. U. (2016). Psychotropic drug prescriptions in Western European nursing homes. International Psychogeriatrics, 28(11), 1775–1790. doi:https://doi.org/10.1017/S1041610216001150
- Jennings, A. A., Foley, T., Walsh, K. A., Coffey, A., Browne, J. P., & Bradley, C. P. (2018). General practitioners’ knowledge, attitudes, and experiences of managing behavioural and psychological symptoms of dementia: A mixed-methods systematic review. International Journal of Geriatric Psychiatry, 33(9), 1163–1176. doi:https://doi.org/10.1186/s13643-018-0732-7
- Johnson, M. J., & May, C. R. (2015). Promoting professional behaviour change in healthcare: What interventions work, and why? A theory-led overview of systematic reviews. BMJ Open, 5(9), e008592. doi:https://doi.org/10.1136/bmjopen-2015-008592
- Jutkowitz, E., Brasure, M., Fuchs, E., Shippee, T., Kane, R. A., Fink, H. A., … Kane, R. L. (2016). Care-delivery interventions to manage agitation and aggression in dementia nursing home and assisted living residents: A systematic review and meta-analysis . Journal of the American Geriatrics Society, 64(3), 477–488. doi:https://doi.org/10.1111/jgs.13936
- Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). Assessment and management of behavioral and psychological symptoms of dementia. BMJ (Clinical Research ed.), 350, h369. doi:https://doi.org/10.1136/bmj.h369
- Legere, L. E., McNeill, S., Schindel Martin, L., Acorn, M., & An, D. (2018). Nonpharmacological approaches for behavioural and psychological symptoms of dementia in older adults: A systematic review of reviews. Journal of Clinical Nursing, 27(7–8), e1360–e1376. doi:https://doi.org/10.1111/jocn.14007
- Livingston, G., Kelly, L., Lewis-Holmes, E., Baio, G., Morris, S., Patel, N., … Cooper, C. (2014). A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technology Assessment (Winchester, England), 18(39), 1–226. doi:https://doi.org/10.3310/hta18390
- Ma, D., Zhao, Y., Wan, Z., Sun, D., Li, H., Xie, Z., & Sun, J. (2020). Nurses’ attitudes and views on the application of antipsychotics in patients with dementia: A systematic review of qualitative studies. Geriatric Nursing, 41(6), 669–676. doi:https://doi.org/10.1016/j.gerinurse.2019.10.007
- Maust, D. T., & Kales, H. C. (2017). Medicating distress. JAMA Internal Medicine, 177(1), 42–43. doi:https://doi.org/10.1001/jamainternmed.2016.7528
- Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry, 72(5), 438–445. doi:https://doi.org/10.1001/jamapsychiatry.2014.3018
- Maust, D. T., Langa, K. M., Blow, F. C., & Kales, H. C. (2017). Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA. International Journal of Geriatric Psychiatry, 32(2), 164–174. doi:https://doi.org/10.1002/gps.4452
- Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. doi:https://doi.org/10.1371/journal.pmed.1000097
- National Institute for Health and Care Excellence. (2018). Dementia: Assessment, management and support for people living with dementia and their carers (NICE Guideline No. 97). London. https://www.nice.org.uk/guidance/ng97.
- Pink, J., O’Brien, J., Robinson, L., & Longson, D. (2018). Dementia: Assessment, management and support: Summary of updated NICE guidance. BMJ, 361,k2438. doi:https://doi.org/10.1136/bmj.k2438
- Pollock, M., Fernandes, R. M., Becker, L. A., Pieper, D., & Hartling, L. (2020). Chapter V: Overviews of reviews. In J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston T. Li, M. J. Page, & V. A. Welch (Eds.), Cochrane handbook of systematic reviews of interventions (version 6.1). London: Cochrane. www.training.cochrane.org/handbook
- Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., … Munro, C. A. (2014). Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial. JAMA, 311(7), 682–691. doi:https://doi.org/10.1001/jama.2014.93
- Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017). A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European Journal of Clinical Pharmacology, 73(8), 927–935. doi:https://doi.org/10.1007/s00228-017-2257-8
- Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Jibson, M. D., … Tan, Z. S. (2016). The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. The American Journal of Psychiatry, 173(5), 543–546. doi:https://doi.org/10.1176/appi.ajp.2015.173501
- Richter, T., Meyer, G., Mohler, R., & Kopke, S. (2012). Psychosocial interventions for reducing antipsychotic medication in care home residents. The Cochrane Database of Systematic Reviews, 12, CD008634. doi:https://doi.org/10.1002/14651858.CD008634.pub2
- Rochon, P. A., & Gurwitz, J. H. (2017). The prescribing cascade revisited. The Lancet, 389(10081), 1778–1780. doi:https://doi.org/10.1016/S0140-6736(17)31188-1
- Sawan, M., Jeon, Y.-H., & Chen, T. F. (2018). Relationship between organizational culture and the use of psychotropic medicines in nursing homes: A systematic integrative review. Drugs & Aging, 35(3), 189–211. doi:https://doi.org/10.1007/s40266-018-0527-5
- Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., … Kristjansson, E. (2017). AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, j4008. doi:https://doi.org/10.1136/bmj.j4008
- Sheehan, R., Strydom, A., Brown, E., Marston, L., & Hassiotis, A. (2018). Association of focused medication review with optimization of psychotropic drug prescribing: A systematic review and meta-analysis. JAMA Network Open, 1(6), e183750. doi:https://doi.org/10.1001/jamanetworkopen.2018.3750
- Stall, N. M., Zipursky, J. S., Rangrej, J., Jones, A., Costa, A. P., Hillmer, M. P., & Brown, K. (2021). Assessment of psychotropic drug prescribing among nursing home residents in Ontario, Canada, during the COVID-19 pandemic. JAMA Internal Medicine, doi:https://doi.org/10.1001/jamainternmed.2021.0224
- Tadrous, M., Fung, K., Desveaux, L., Gomes, T., Taljaard, M., Grimshaw, J. M., … Ivers, N. M. (2020). Effect of academic detailing on promoting appropriate prescribing of antipsychotic medication in nursing homes: A cluster randomized clinical trial. JAMA Network Open, 3(5), e205724–e205724. doi:https://doi.org/10.1001/jamanetworkopen.2020.5724
- Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S. (2016). Antipsychotic use in dementia: A systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease, 7(5), 229–245. doi:https://doi.org/10.1177/2040622316658463
- Thompson Coon, J., Abbott, R., Rogers, M., Whear, R., Pearson, S., Lang, I., … Stein, K. (2014). Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: A systematic review. Journal of the American Medical Directors Association, 15(10), 706–718. doi:https://doi.org/10.1016/j.jamda.2014.06.012
- van der Spek, K., Gerritsen, D. L., Smalbrugge, M., Nelissen-Vrancken, M. H., Wetzels, R. B., Smeets, C. H., … Koopmans, R. T. (2016). Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. International Psychogeriatrics, 28(10), 1589–1595. doi:https://doi.org/10.1017/S104161021600082X
- van der Steen, J., Smaling, H., van der Wouden, J., Bruinsma, M., Scholten, R., & Vink, A. (2018). Music-based therapeutic interventions for people with dementia. Cochrane Database of Systematic Reviews, 7, CD003477. doi:https://doi.org/10.1002/14651858.CD003477.pub4
- Velayudhan, L., Aarsland, D., & Ballard, C. (2020). Mental health of people living with dementia in care homes during COVID-19 pandemic. International Psychogeriatrics, 32(10), 1253–1254. doi:https://doi.org/10.1017/S1041610220001088
- Walsh, K. A., Dennehy, R., Sinnott, C., Browne, J., Byrne, S., McSharry, J., … Timmons, S. (2017). Influences on decision-making regarding antipsychotic prescribing in nursing home residents with dementia: A systematic review and synthesis of qualitative evidence. Journal of the American Medical Directors Association, 18(10), 897.e1. doi:https://doi.org/10.1016/j.jamda.2017.06.032
- Wensing, M., Wollersheim, H., & Grol, R. (2006). Organizational interventions to implement improvements in patient care: A structured review of reviews. Implementation Science, 1(2). doi:https://doi.org/10.1186/1748-5908-1-2
- Westbury, J., Gee, P., Ling, T., Kitsos, A., & Peterson, G. (2019). More action needed: Psychotropic prescribing in Australian residential aged care. Australian & New Zealand Journal of Psychiatry, 53(2), 136–147. doi:https://doi.org/10.1177/0004867418758919